This document provides guidance for minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products. When applicable, read together with Joint Committee on Proprietary Medicinal Products / CVMP note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products: Explanatory note for ... and
Gelatin for use in pharmaceuticals: explanatory note (13 december 2000) on the manufacture of gelatin in relationship to the CPMP note For guidance on minimising the risk of transmitting Animal Spongiform Encephalopathy ... .
Keywords: Bovine spongiform encephalopathy (BSE), transmissible spongiform encephalopathy (TSE), Creutzfeldt-Jakob disease (CJD)